Table of contents
Volume 100, Issue 3
Published online 3 February 2009 (431-561)
Review
Integrating BRAF/MEK inhibitors into combination therapy for melanoma
K S M Smalley and K T Flaherty
Br J Cancer 100: 431-435; advance online publication, January 20, 2009; doi:10.1038/sj.bjc.6604891
Clinical Studies
The risk of febrile neutropenia in patients with non-small-cell lung cancer treated with docetaxel: a systematic review and meta-analysis
A Wailoo, A Sutton and A Morgan
Br J Cancer 100: 436-441; doi:10.1038/sj.bjc.6604863
Exemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trial FREE
A Barnadas, M Gil, S González, I Tusquets, M Muñoz, A Arcusa, L Prieto, M Margelí-Vila and A Moreno
Br J Cancer 100: 442-449; advance online publication, January 20, 2009; doi:10.1038/sj.bjc.6604868
Association between serum 25(OH)D and death from prostate cancer
S Tretli, E Hernes, J P Berg, U E Hestvik and T E Robsahm
Br J Cancer 100: 450-454; advance online publication, January 20, 2009; doi:10.1038/sj.bjc.6604865
Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy
C E Kiserud, A Fosså, T Bjøro, H Holte, M Cvancarova and S D Fosså
Br J Cancer 100: 455-463; advance online publication, January 20, 2009; doi:10.1038/sj.bjc.6604892
A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811)
H Kunitoh, T Tamura, T Shibata, M Imai, Y Nishiwaki, M Nishio, A Yokoyama, K Watanabe, K Noda and N Saijo JCOG Lung Cancer Study Group, Tokyo, Japan
Br J Cancer 100: 464-469; advance online publication, January 20, 2009; doi:10.1038/sj.bjc.6604866
Translational Therapeutics
HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer)
L Plowright, K J Harrington, H S Pandha and R Morgan
Br J Cancer 100: 470-475; advance online publication, January 20, 2009; doi:10.1038/sj.bjc.6604857
BCRP expression does not result in resistance to STX140 in vivo, despite the increased expression of BCRP in A2780 cells in vitro after long-term STX140 exposure
J M Day, P A Foster, H J Tutill, S P Newman, Y T Ho, M P Leese, B V L Potter, M J Reed and A Purohit
Br J Cancer 100: 476-486; advance online publication, January 20, 2009; doi:10.1038/sj.bjc.6604873
Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients
J D Barros-Silva, D Leitão, L Afonso, J Vieira, M Dinis-Ribeiro, M Fragoso, M J Bento, L Santos, P Ferreira, S Rêgo, C Brandão, F Carneiro, C Lopes, F Schmitt and M R Teixeira
Br J Cancer 100: 487-493; advance online publication, January 20, 2009; doi:10.1038/sj.bjc.6604885
Molecular Diagnostics
Validation study of the prognostic value of cyclin-dependent kinase (CDK)-based risk in Caucasian breast cancer patients
J G H van Nes, V T H B M Smit, H Putter, P J Kuppen, S J Kim, M Daito, J Ding, M Shibayama, S Numada, K Gohda, T Matsushima, H Ishihara, S Noguchi and C J H van de Velde
Br J Cancer 100: 494-500; advance online publication, January 20, 2009; doi:10.1038/sj.bjc.6604870
Frequent overexpression of HMGA1 and 2 in gastroenteropancreatic neuroendocrine tumours and its relationship to let-7 downregulation
M M Rahman, Z R Qian, E L Wang, R Sultana, E Kudo, M Nakasono, T Hayashi, S Kakiuchi and T Sano
Br J Cancer 100: 501-510; advance online publication, January 20, 2009; doi:10.1038/sj.bjc.6604883
Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer
C L Andersen, L L Christensen, K Thorsen, T Schepeler, F B Sørensen, H W Verspaget, R Simon, M Kruhøffer, L A Aaltonen, S Laurberg and T F Ørntoft
Br J Cancer 100: 511-523; advance online publication, January 20, 2009; doi:10.1038/sj.bjc.6604884
Epidemiology
Family history of haematopoietic malignancies and non-Hodgkin's lymphoma risk in the California Teachers Study
Y Lu, J Sullivan-Halley, W Cozen, E T Chang, K Henderson, H Ma, D Deapen, C Clarke, P Reynolds, S L Neuhausen, H Anton-Culver, G Ursin, D West and L Bernstein
Br J Cancer 100: 524-526; advance online publication, January 20, 2009; doi:10.1038/sj.bjc.6604881
An analysis of temporal and generational trends in the incidence of anal and other HPV-related cancers in Southeast England
D Robinson, V Coupland and H Møller
Br J Cancer 100: 527-531; advance online publication, January 20, 2009; doi:10.1038/sj.bjc.6604871
Different cervical cancer screening approaches in a Chinese multicentre study
N Li, J-F Shi, S Franceschi, W-H Zhang, M Dai, B Liu, Y-Z Zhang, L-K Li, R-F Wu, H De Vuyst, M Plummer, Y-L Qiao and G Clifford
Br J Cancer 100: 532-537; advance online publication, January 6, 2009; doi:10.1038/sj.bjc.6604840
Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis
G K Reeves, K Pirie, J Green, D Bull and V Beral for the Million Women Study Collaborators
Br J Cancer 100: 538-544; doi:10.1038/sj.bjc.6604853
Breast cancer incidence, stage, treatment and survival in ethnic groups in South East England
R H Jack, E A Davies and H Møller
Br J Cancer 100: 545-550; advance online publication, January 6, 2009; doi:10.1038/sj.bjc.6604852
Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis
C C Abnet, N D Freedman, F Kamangar, M F Leitzmann, A R Hollenbeck and A Schatzkin
Br J Cancer 100: 551-557; advance online publication, January 20, 2009; doi:10.1038/sj.bjc.6604880
Dietary glycemic load and gastric cancer risk in Italy
P Bertuccio, D Praud, L Chatenoud, E Lucenteforte, C Bosetti, C Pelucchi, M Rossi, E Negri and C La Vecchia
Br J Cancer 100: 558-561; doi:10.1038/sj.bjc.6604894
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
